{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T10:24:42Z","timestamp":1743675882015,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"crossref","award":["2208085MH217"],"award-info":[{"award-number":["2208085MH217"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunogenetics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00251-023-01314-8","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T12:42:50Z","timestamp":1687437770000},"page":"395-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic value of the WT-1 gene combined with recurrent cytogenetic genes in acute myeloid leukemia"],"prefix":"10.1007","volume":"75","author":[{"given":"Qing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haotian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shudao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianshan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"1314_CR1","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1182\/blood.2020010477","volume":"138","author":"C Augsberger","year":"2021","unstructured":"Augsberger C, H\u00e4nel G, Xu W et al (2021) Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody. Blood 138:2655\u20132669. https:\/\/doi.org\/10.1182\/blood.2020010477","journal-title":"Blood"},{"key":"1314_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.7754\/Clin.Lab.2017.170915","volume":"64","author":"MA Bani-Ahmad","year":"2018","unstructured":"Bani-Ahmad MA, Al-Sweedan SA, Al-Asseiri MA et al (2018) A proposed kinetic model for the diagnostic and prognostic value of WT1 and p53 in acute myeloid leukemia. Clin Lab 64:357\u2013363. https:\/\/doi.org\/10.7754\/Clin.Lab.2017.170915","journal-title":"Clin Lab"},{"key":"1314_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3324\/%25x","volume":"89","author":"E Barrag\u00e1n","year":"2004","unstructured":"Barrag\u00e1n E, Cervera J, Bolufer P et al (2004) Prognostic implications of Wilms\u2019 tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Haematologica 89:926\u2013933. https:\/\/doi.org\/10.3324\/%25x","journal-title":"Haematologica"},{"key":"1314_CR4","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1182\/blood.V90.3.1217","volume":"90","author":"L Bergmann","year":"1997","unstructured":"Bergmann L, Miething C, Maurer U et al (1997) High levels of Wilms\u2019 tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 90:1217\u20131225. https:\/\/doi.org\/10.1182\/blood.V90.3.1217","journal-title":"Blood"},{"key":"1314_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.leukres.2017.10.010","volume":"63","author":"A Candoni","year":"2017","unstructured":"Candoni A, De Marchi F, Zannier ME et al (2017) High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission. Leuk Res 63:22\u201327. https:\/\/doi.org\/10.1016\/j.leukres.2017.10.010","journal-title":"Leuk Res"},{"key":"1314_CR6","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41591-019-0472-9","volume":"25","author":"AG Chapuis","year":"2019","unstructured":"Chapuis AG, Egan DN, Bar M et al (2019) T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant. Nat Med 25:1064\u20131072. https:\/\/doi.org\/10.1038\/s41591-019-0472-9","journal-title":"Nat Med"},{"key":"1314_CR7","doi-asserted-by":"publisher","first-page":"153303382110521","DOI":"10.1177\/15330338211052152","volume":"20","author":"C Chen","year":"2021","unstructured":"Chen C, Chen Z, Chio CL et al (2021) Higher expression of WT1 with lower CD58 expression may be biomarkers for risk stratification of patients with cytogenetically normal acute myeloid leukemia. Technol Cancer Res Treat 20:15330338211052152. https:\/\/doi.org\/10.1177\/15330338211052152","journal-title":"Technol Cancer Res Treat"},{"key":"1314_CR8","doi-asserted-by":"publisher","unstructured":"Chen X, Xie H, Wood BL et al (2015) Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.\u00a0J Clin Oncol 33:1258\u20131264. https:\/\/doi.org\/10.1200\/JCO.2014.58.3518","DOI":"10.1200\/JCO.2014.58.3518"},{"key":"1314_CR9","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.bbmt.2016.03.005","volume":"22","author":"C Di Grazia","year":"2016","unstructured":"Di Grazia C, Pozzi S, Geroldi S et al (2016) Wilms Tumor 1 expression and pre-emptive immunotherapy in patients with acute myeloid leukemia undergoing an allogeneic hemopoietic stem cell transplantation. Biol Blood Marrow Transplant 22:1242\u20131246. https:\/\/doi.org\/10.1016\/j.bbmt.2016.03.005","journal-title":"Biol Blood Marrow Transplant"},{"key":"1314_CR10","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner H, Weisdorf DJ, Bloomfield CD (2015) Acute myeloid leukemia. N Engl J Med 373:1136\u20131152. https:\/\/doi.org\/10.1056\/NEJMra1406184","journal-title":"N Engl J Med"},{"key":"1314_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3785\/j.issn.1008-9292.2019.02.09","volume":"48","author":"D Du","year":"2019","unstructured":"Du D, Zhu L, Wang Y et al (2019) Expression of WT1 gene and its prognostic value in patients with acute myeloid leukemia. Zhejiang Da Xue Xue Bao Yi Xue Ban 48:50\u201357. https:\/\/doi.org\/10.3785\/j.issn.1008-9292.2019.02.09","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"1314_CR12","unstructured":"Goel H, Rahul E, Gupta AK et al (2020) Molecular update on biology of Wilms Tumor 1 gene and its applications in acute myeloid leukemia.\u00a0Am J Blood Res 10:151\u2013160.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7675129\/"},{"key":"1314_CR13","doi-asserted-by":"publisher","unstructured":"King-Underwood L, Pritchard-Jones K (1998) Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance.\u00a0Blood 91:2961\u20132968. https:\/\/doi.org\/10.1182\/blood.V91.8.2961.2961_2961_2968","DOI":"10.1182\/blood.V91.8.2961.2961_2961_2968"},{"key":"1314_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MOH.0000000000000567","volume":"27","author":"A Kishtagari","year":"2020","unstructured":"Kishtagari A, Levine RL, Viny AD (2020) Driver mutations in acute myeloid leukemia. Curr Opin Hematol 27:49\u201357. https:\/\/doi.org\/10.1097\/MOH.0000000000000567","journal-title":"Curr Opin Hematol"},{"key":"1314_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3760\/cma.j.issn.0253-2727.2017.03.001","volume":"38","author":"Leukemia & Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association","year":"2017","unstructured":"Leukemia and Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association (2017) Chinese guidelines for diagnosis and treatment of adult acute myeloid leukemia (not APL). Zhonghua Xue Ye Xue Za Zhi 38:177\u2013182. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2017.03.001","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"1314_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3760\/cma.j.issn.0253-2727.2014.05.024","volume":"35","author":"Ma J; Chinese Society of Hematology, Chinese Medical Association & Chinese Society of Hematologist, Chinese Medical Doctor Association","year":"2014","unstructured":"Ma J, Chinese Society of Hematology, Chinese Medical Association and Chinese Society of Hematologist, Chinese Medical Doctor Association (2014) Chinese guidelines for diagnosis and treatment of acute promyelocytic leukemia. Zhonghua Xue Ye Xue Za Zhi 35:475\u2013447. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2014.05.024","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"1314_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.clml.2016.12.006","volume":"17","author":"I Marjanovic","year":"2017","unstructured":"Marjanovic I, Karan-Djurasevic T, Ugrin M et al (2017) Use of Wilms tumor 1 gene expression as a reliable marker for prognosis and minimal residual disease monitoring in acute myeloid leukemia with normal karyotype patients. Clin Lymphoma Myeloma Leuk 17:312\u2013319. https:\/\/doi.org\/10.1016\/j.clml.2016.12.006","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1314_CR18","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.1016\/j.clml.2018.07.298","volume":"18","author":"K Mashima","year":"2018","unstructured":"Mashima K, Oh I, Ikeda T et al (2018) Role of sequential monitoring of WT1 gene expression in patients with acute myeloid leukemia for the early detection of leukemia relapse. Clin Lymphoma Myeloma Leuk 18:e521\u2013e527. https:\/\/doi.org\/10.1016\/j.clml.2018.07.298","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1314_CR19","doi-asserted-by":"publisher","unstructured":"Potluri S, Assi SA, Chin PS et al (2021) Isoform-specific and signaling-dependent propagation of acute myeloid leukemia by Wilms tumor 1.\u00a0Cell Rep 35:109010. https:\/\/doi.org\/10.1016\/j.celrep.2021.109010","DOI":"10.1016\/j.celrep.2021.109010"},{"key":"1314_CR20","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.leukres.2013.06.018","volume":"37","author":"K Vidovic","year":"2013","unstructured":"Vidovic K, Ullmark T, Rosberg B et al (2013) Leukemia associated mutant Wilms\u2019 tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells. Leuk Res 37:1341\u20131349. https:\/\/doi.org\/10.1016\/j.leukres.2013.06.018","journal-title":"Leuk Res"},{"key":"1314_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3389\/fonc.2019.00655","volume":"9","author":"MT Voso","year":"2019","unstructured":"Voso MT, Ottone T, Lavorgna S et al (2019) MRD in AML: The role of new techniques. Front Oncol 9:655. https:\/\/doi.org\/10.3389\/fonc.2019.00655","journal-title":"Front Oncol"},{"key":"1314_CR22","unstructured":"Yamauchi T, Negoro E, Lee S et al (2013) Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia: a single institution's experience. Anticancer Res 33:3335\u20133340. https:\/\/ar.iiarjournals.org\/content\/33\/8\/3335.long"},{"key":"1314_CR23","doi-asserted-by":"publisher","unstructured":"Yang YN, Wang XR, Zhao CX et al (2015) Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis.\u00a0Ann Hematol 94:929\u2013938. https:\/\/doi.org\/10.1007\/s00277-014-2295-6","DOI":"10.1007\/s00277-014-2295-6"},{"key":"1314_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12967-020-02384-y","volume":"18","author":"B Zhou","year":"2020","unstructured":"Zhou B, Jin X, Jin W et al (2020) WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target. J Transl Med 18:254. https:\/\/doi.org\/10.1186\/s12967-020-02384-y","journal-title":"J Transl Med"}],"container-title":["Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-023-01314-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00251-023-01314-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-023-01314-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T12:09:18Z","timestamp":1689682158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00251-023-01314-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1314"],"URL":"https:\/\/doi.org\/10.1007\/s00251-023-01314-8","relation":{},"ISSN":["0093-7711","1432-1211"],"issn-type":[{"type":"print","value":"0093-7711"},{"type":"electronic","value":"1432-1211"}],"subject":[],"published":{"date-parts":[[2023,6,22]]},"assertion":[{"value":"22 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Helsinki Declaration II and was approved by the Institutional Review Board of the Second Affiliated Hospital of Anhui Medical University (No.2012991).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All\u00a0authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}